Almost every year, it seems a pandemic is hyped up. I would argue that’s because: • They give federal agencies (e.g., the CDC) a way to justify their necessity and get Congressional funding. • The media thrives off of hooking the public through fear and appeasing its sponsors (e.g., the pharmaceutical industry). • It sustains… Read More: The Grotesque Bird Flu Scam and How Colds or Flus… »
As Biogen’s new Alzheimer’s drug Aduhelm makes headlines nearly every day—many covering the drug’s slower-than-expected uptake—one team of biopharma analysts is lowering its 2021 expectations for the med. Nonetheless, despite the drug sputtering out the gate, the team still sees a multibillion-dollar sales opportunity for the company in Alzheimer’s disease. Writing to investors Wednesday, analysts with RBC Capital Markets… Read More: Despite rough start, Biogen’s Aduhelm should find footing, analysts say.… »
By now, we’ve all established that sleeping is real important, right? And while downing CBD, buying fancy-ass sheets, and settling in for a bedtime story from Harry Styles helps, none of it matters if you wake up at 2 a.m. sweaty or as a human ice cube. That’s where finding ze right fit for your… Read More: Should You Rest Your Weary Bones Beneath a Quilt or… »
A Harvard immunologist said current vaccines appear to be effective enough to end the pandemic, despite growing concerns that more infectious COVID-19 variants would severely blunt the effectiveness of the preventative treatments and set the nation back in its fight against the disease. Galit Alter, professor of medicine at Harvard Medical School and the Ragon… Read More: Vaccines should end the pandemic, despite the variants, say experts »